Adar Poonawalla announces decision to bid for RCB
Serum Institute of India (SII) CEO Adar Poonawala on Thursday announced the decision to bid for the defending...
Current Covid variants are mild: Serum CEO Adar Poonawala
Covovax to get booster dose approval in 10-15 days: SII CEO
Covid situation in India better: SII CEO Adar Poonawalla
Serum Institute of India CEO Adar Poonawalla on Sunday lauded India's fight against the Covid pandemic, saying...
Rising COVID cases news from China is concerning: SII CEO
Adar Poonawala also urged the people to adhere to the guidelines set by the Government of India and the Ministry...
Posing as Adar Poonawalla, scammers dupe SII of Rs 1 cr, 7 nabbed
'HPV vaccine production to start in first quarter of 2023'
New Delhi [India], October 21 (ANI): The production of India's first indigenously developed quadrivalent Human...
Cost of 'CERVAVAC' will be between Rs 200-400: Poonawala
New Delhi [India], September 1 (ANI: India's first indigenously developed quadrivalent Human Papilloma Virus...
COVID-19 vaccine Covovax now available for children in India
NTAGI approves SII's Covovax for 12-17 age group: Sources
SII CEO claims Made in India COVID vaccines better than Pfizer
New Delhi [India], April 13 (ANI): Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday claimed that...
We feel energised, encouraged by PM Modi's vision for vaccine...
Copyright © aninews.in | All Rights Reserved.